RASSF1 and hepatocellular carcinoma: Our study showed that RASSF1A aberrant hypermethylation could detect HCC in cirrhotic patients with 65% sensitivity, 70% specificity, 68.42% PPV, 66.67% NPV, and 67.5% accuracy.